The Abu Dhabi based pharmaceutical producer, Neopharma, is all set to introduce 8 new brands in the domestic market. These products will further strengthen the company’s franchise in the antibiotics, analgesics and respiratory medicine segments. The introduction also marks Neopharma’s foray into the nutritional supplements market.
With these new products entering into the market, Neopharma’s total tally of offerings will increase to 42 products. Talking on this expanded product offerings, Dr. B R Shetty, Managing Director & CEO, remarked that the company’s ability to introduce new products in quick succession emerges from a well orchestrated cohesive effort and serves as an important competitive advantage.
The company has had an impressive start in the domestic market and is today known for its innovative range, quality formulations and competitive prices. With exports on full swing, the expanded product mix is all set to propel the company into the elite list of top pharmaceutical players in the region.